Research Article| Volume 27, ISSUE 9, P968-974, May 01, 1990

Download started.


Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats

      This paper is only available as a PDF. To read, Please Download here.


      Several clinical investigations have suggested that captopril, an angiotensin-converting enzyme inhibitor (ACEI), currently used as an antihypertensive agent, exhibited antidepressant properties in humans. The present experiment was evaluated for potential antidepressive activity of captopril on the learned helplessness paradigm in rats. Captopril (8, 16, 32 mg/kg/day, IP) induced a reversal of escape deficits but did not affect significantly the motor activity, suggesting that this effect was not due to motor stimulation. This antidepressant-like activity was comparable to that of imipramine (16, 32 mg/kg/day, IP). Naloxone (0.5; 1 mg/kg, IP) blocked the effect of captopril (16 mg/kg, IP) in this test. These results suggest that an opioid mediation could be responsible at least in part for its behavioral effect.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bengis R.-G.
        • Coleman T.G.
        • Young D.D.
        • Mc Caa R.E.
        Long term blockade of angiotensin formation in various normotensive and hypertensive rat models using converting enzyme inhibitor (SQ 14.225).
        Circ Res. 1978; 43: 145-153
        • Charney D.S.
        • Menkes D.B.
        • Heninger G.R.
        Receptor sensitivity and the mechanism of action and antidepressant treatment: Implications for the etiology and therapy of depression.
        Arch Gen Psychiatry. 1981; 38: 160-180
        • Cohen B.M.
        • Zubenko G.S.
        Captopril in the treatment of recurrent major depression (letter).
        J Clin Psychopharmacol. 1988; 8: 143-144
        • Cohen L.
        • Anderson G.
        • White R.F.
        • Griffing G.
        • Melby J.
        Enalapril and hypertension.
        Am J Psychiatry. 1984; 141: 1012-1013
        • Croog S.H.
        • Levine S.
        • Testa M.A.
        • Brown B.
        • Bulpitt C.J.
        • Jenkins D.
        • Klerman G.L.
        • Williams G.H.
        The effects of anti-hypertensive therapy on the quality of life.
        N Engl J Med. 1986; 314: 1657-1664
        • Deicken R.F.
        Captopril treatment of depression.
        Biol Psychiatry. 1986; 21: 1425-1428
        • Erdos E.G.
        • Skidgel R.A.
        The angiotensin I-converting enzyme.
        Lab Invest. 1987; 56: 345-348
        • Etienne P.E.
        • Zubenko G.S.
        Does captopril elevate mood?.
        Trends Pharmacol Sci. 1987; 8: 329-330
        • Germain L.
        • Chouinard G.
        Treatment of recurrent unipolar major depression with captopril.
        Biol Psychiatry. 1988; 23: 637-641
        • Germain L.
        • Chouinard G.
        Captopril treatment of major depression with serial measurements of blood cortisol concentrations.
        Biol Psychiatry. 1989; 25: 489-493
        • Giardian W.J.
        • Ebert D.M.
        Positive effects of captopril in the behavioral despair swim test.
        Biol Psychiatry. 1989; 25: 697-702
        • Gillman M.A.
        • Sandyk R.
        Reversal of captopril-induced psychosis with naloxone.
        Am J Psychiatry. 1985; 142: 270-274
        • Hell R.C.
        • Brogden R.N.
        • Splight T.M.
        • Avery G.S.
        Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
        Drugs. 1980; 20: 409-452
        • Martin P.
        • Soubrié P.
        • Simon P.
        Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoceptor stimulants clenbuterol and salbutamol.
        Pharmacol Biochem Behav. 1986; 24: 177-186
        • Martin P.
        • Soubrié P.
        • Simon P.
        Noradrenergic and opioid mediation of tricyclic-induced reversal of escape deficits caused by inescapable shock pretreatment in rats.
        Psychopharmacology. 1986; 90: 90-94
        • Massol J.
        • Martin P.
        • Adessi G.
        • Puech A.J.
        GnRH as antidepressant: a psychopharmacological animal study.
        Eur J Pharmacol. 1989; 160: 395-399
        • Printz M.P.
        • Ganten D.
        • Unger T.
        • Philipps M.I.
        The brain renin-angiotensin system.
        Exp. Brain Res. 1982; : 5-22
        • Telner J.I.
        • Singhal R.L.
        Effects of nortrptyline treatment on learned helplessness in the rat.
        Pharmacol Biochem Behav. 1981; 14: 823-826
        • Turkkan J.S.
        Behavioral performance affects of antihypertensive drugs: Human and animal studies.
        Neurosci Biobehav Res. 1988; 12: 111-122
        • Willner P.
        The validity of animal models of depression.
        Psychopharmacology. 1984; 83: 1-10
        • Zubenko G.S.
        • Nixon R.A.
        Mood elevating effect of captopril in depressed patients.
        Am J Psychiatry. 1984; 141: 110-111